Liang‐In Lin

17.2k citations

154 papers · 12.1k indexed · 2 hit papers · h-index 39

Impact in

Molecular Medicine top 0.2%
- Curcumin's Biomedical Applications
Hematology top 0.5%
- Acute Myeloid Leukemia Research

Papers in

Hematology 41
- Acute Myeloid Leukemia Research 33
Genetics 28
- Myeloproliferative Neoplasms: Diagnosis and Treatment 16

Co-authors: Ann‐Lii Cheng Jen‐Kun Lin Ying‐Jan Wang Min‐Hsiung Pan Chang‐Yao Hsieh Yuan‐Soon Ho Hwei‐Fang Tien Da‐Liang Ou
Journals: Blood (10 papers)Blood Cancer Journal (5 papers)DNA repair (5 papers)British Journal of Cancer (4 papers)PLoS ONE (4 papers)
Partner nations: Taiwan United States China

In The Last Decade

Liang‐In Lin

146 papers receiving 11.9k citations

Hit Papers

align trajectories log scale

Stability of curcumin in buffer solutions and characterization of its degradation products 1997 · 1.4k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1997 Journal of Pharmaceutical and Biomedical Analysis
1989 Biometrics

Peers

Countries citing papers authored by Liang‐In Lin

Since Specialization

Citations

This map shows the geographic impact of Liang‐In Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang‐In Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang‐In Lin more than expected).

Fields of papers citing papers by Liang‐In Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liang‐In Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang‐In Lin. The network helps show where Liang‐In Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Liang‐In Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Liang‐In Lin Line = papers co-authored together Liang‐In Lin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Jaceosidin, a natural polymethoxyflavone, suppresses leukemia cell growth and impairs lipid metabolism-dependent survival in AML and cytarabine-resistant cells Biomedicine & Pharmacotherapy ·Trung Quy Phan, Je-Wen Liou, Liang‐In Lin, Gentaro NAITO, Ming‐Jiuan Wu, Pei‐Yi Chen, Jui-Hung Yen	2025	0
2	Furo[2,3- f ]quinazolin-7(6 H )-one Derivatives as Potent, Selective, and Orally Bioavailable MAT2A Inhibitors for MTAP-Deficient Cancer Therapy Journal of Medicinal Chemistry ·MW Shields, cI c, Liang‐In Lin, F. Gei szlig ler, Philippe Waille, Yaoliang Sun, Rongrong Cui, Sulin Zhang, Mingyue Zheng, Shilin Xu	2025	0
3	Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations Blood Cancer Journal ·Feng‐Ming Tien, Chi‐Yuan Yao, Cheng‐Hong Tsai, Xong Hai, Chien‐Yuan Chen, RC Mingroni‐Netto, Chien‐Chin Lin, Yuan‐Yeh Kuo, Yen‐Ling Peng, Mei‐Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang‐In Lin, José Orión Castellón, Bor‐Sheng Ko, Ming Yao, Jih‐Luh Tang, Wen‐Chien Chou, Hsin‐An Hou, Hwei‐Fang Tien	2024	8
4	Shikonin, a natural naphthoquinone phytochemical, exerts anti-leukemia effects in human CBF-AML cell lines and zebrafish xenograft models Biomedicine & Pharmacotherapy ·Jui-Hung Yen, 叶昌柱, Pervanidou Danai, Lanise Lacey, Manula Wijewardene, Je-Wen Liou, Yara B. Jallad, Liang‐In Lin, Pei‐Yi Chen	2024	2
5	Pinostrobin modulates FOXO3 expression, nuclear localization, and exerts antileukemic effects in AML cells and zebrafish xenografts Chemico-Biological Interactions ·Pei‐Yi Chen, Ching-Yen Lin, Felix Mandl, 叶昌柱, Je-Wen Liou, Manula Wijewardene, Liang‐In Lin, Jui-Hung Yen	2023	5
6	Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification Blood Cancer Journal ·RC Mingroni‐Netto, 土井康作, Cheng‐Hong Tsai, Feng‐Ming Tien, Xong Hai, Mei‐Hsuan Tseng, Yuan‐Yeh Kuo, Ming-Chih Liu, Achmad Wachidul Kohar, スリーラットウォンサミン, Jih‐Luh Tang, Szu-Ying Chen, N. Pelletier, Liang‐In Lin, Wen‐Chien Chou, Chien‐Chin Lin, Hsin‐An Hou, Hwei‐Fang Tien	2023	12
7	Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia American Journal of Hematology ·Xong Hai, Cheng‐Hong Tsai, Chien‐Chin Lin, Feng‐Ming Tien, Yuan‐Yeh Kuo, RC Mingroni‐Netto, Yen‐Ling Peng, A. V. Bychkova, Mei‐Hsuan Tseng, 広道鷺谷, スリーラットウォンサミン, Liang‐In Lin, Szu-Ying Chen, N. Pelletier, Bor‐Sheng Ko, Jih‐Luh Tang, Ming Yao, Wen‐Chien Chou, Hsin‐An Hou, Hwei‐Fang Tien	2023	19
8	Phosphoproteomics Reveals the Role of Constitutive KAP1 Phosphorylation by B-cell Receptor Signaling in Chronic Lymphocytic Leukemia Molecular Cancer Research ·Shelby Rinehart, Hsin‐Yi Wu, Shang‐Ju Wu, Gabriele Enders, Sabina K. Guedes-García, Kuen‐Tyng Lin, Liang‐In Lin, Chi‐Yuan Yao, 山本元道, Wael Dahhan, Takashi Angata, Hwei‐Fang Tien, Yu‐Ju Chen, Kuo‐I Lin	2022	0
9	Novel prognostic implications of complement activation in the tumour microenvironment for de novo metastatic BRAF V600E mutant colorectal cancer British Journal of Cancer ·Kuo‐Hsing Chen, Chia‐Lang Hsu, Yu‐Li Su, Chang‐Tsu Yuan, Liang‐In Lin, Jia‐Huei Tsai, 小林孝寛, Ann‐Lii Cheng, Kun‐Huei Yeh	2022	2
10	Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohort British Journal of Cancer ·Kuo‐Hsing Chen, Liang‐In Lin, Chang‐Tsu Yuan, Li‐Hui Tseng, Veronica Dinda Sekar Kristanti, 小林孝寛, Jin‐Tung Liang, Been‐Ren Lin, Ann‐Lii Cheng, Kun‐Huei Yeh	2021	1
11	Assessment of Neuropathic Pain in Ankylosing Spondylitis: Prevalence and Characteristics Pain and Therapy ·Ling Zhou, Ting Li, Xinyu Wu, Xiao Fang, Liang‐In Lin, Lingying Ye, Jian Yin, Juan Zhao, Xiuwen Wang, Elizabeth Dollard, Huji Xu	2021	9
12	Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML Blood Advances ·Cheng‐Hong Tsai, Jih‐Luh Tang, Feng‐Ming Tien, Yuan‐Yeh Kuo, Marilou B. McLaughlin, Chien‐Chin Lin, Mei‐Hsuan Tseng, Yen‐Ling Peng, Myriam Sidán, N. Pelletier, Ming-Chih Liu, Chia‐Wen Liu, Ming Yao, Liang‐In Lin, Wen‐Chien Chou, Chien‐Yu Chen, Hsin‐An Hou, Hwei‐Fang Tien	2021	38
13	A novel frameshift variant in SON causes Zhu‐Tokita‐Takenouchi‐Kim Syndrome Journal of Clinical Laboratory Analysis ·Ya Tan, K. de Reus, Heidari Hadi, Qian Liu, D. E. WOODHAM, Jennifer Iceton, Zhi Li, Yiwen He, Yousheng Yan, Liang‐In Lin	2020	7
14	Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression Clinical Cancer Research ·Chiun Hsu, Liang‐In Lin, Yu‐Che Cheng, А. С. Чалкин, Yu‐Yun Shao, Ann‐Lii Cheng, Da‐Liang Ou	2015	40
15	Cetuximab Might Be Detrimental to Metastatic Colorectal Cancer Patients with KRAS Codon 12 Mutations. PubMed ·Putri Sekar Wangi Sekar, Yulin Lin, Jau‐Yu Liau, Пахомов Михаил Дмитриевич, Jin‐Tung Liang, Been‐Ren Lin, Ji‐Shiang Hung, Li‐Hui Tseng, Liang‐In Lin, Yih‐Leong Chang, Ann‐Lii Cheng, Kun‐Huei Yeh	2015	3
16	Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: association with distinct clinicopathological and molecular features and poor clinical outcome Journal of Clinical Pathology ·Пахомов Михаил Дмитриевич, Jau‐Yu Liau, Yulin Lin, Li‐Hui Tseng, Liang‐In Lin, Kun‐Huei Yeh, Yung‐Ming Jeng	2015	7
17	H3K9 Histone Methyltransferase, KMT1E/SETDB1, Cooperates with the SMAD2/3 Pathway to Suppress Lung Cancer Metastasis Cancer Research ·Pei‐Chun Wu, Jeng‐Wei Lu, Jer‐Yen Yang, I‐Hsuan Lin, Da‐Liang Ou, Yu‐Hsiang Lin, 楠城誉朗, Wenfeng Huang, Wan-Ping Wang, Yih‐Leh Huang, Chiun Hsu, Liang‐In Lin, Yueh‐Min Lin, Chieh‐Yu Shen, Tsai‐Yu Tzeng	2014	56
18	Induction of DNA Damage-Inducible Gene GADD45β Contributes to Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Cells Cancer Research ·Da‐Liang Ou, Ying‐Chun Shen, Sung‐Liang Yu, Kuen‐Feng Chen, 菲尔, Yeni Hasri Utami Jalil, Wen-Chi Feng, KeBo LI, Liang‐In Lin, Chiun Hsu, Ann‐Lii Cheng	2010	68
19	Nucleophosmin Mutations in De novo Acute Myeloid Leukemia: The Age-Dependent Incidences and the Stability during Disease Evolution Cancer Research ·Wen‐Chien Chou, Jih‐Luh Tang, Liang‐In Lin, Ming Yao, Woei Tsay, Chien‐Yuan Chen, Shang‐Ju Wu, Chi‐Fei Huang, J.L. Crane, Mei‐Hsuan Tseng, Dong‐Tsamn Lin, Kai‐Hsin Lin, Yao‐Chang Chen, Hwei‐Fang Tien	2006	115
20	The Incidence of Beta:Thalassemia Trait in Taiwan Lada Stehlíková, Zhong Dian, Alejandro Bayter Marín, Jochen Klingek, Nicole Hersey, Xiaochun Xie, Kuo‐Sin Lin, Liang‐In Lin	1994	3

About Liang‐In Lin

Liang‐In Lin is a scholar working on Hematology, Genetics, Cancer Research, Pathology and Forensic Medicine and Molecular Biology, having authored 154 papers that have together received 12.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (33 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), RNA modifications and cancer (14 papers), Epigenetics and DNA Methylation (12 papers), Genetic factors in colorectal cancer (10 papers), DNA Repair Mechanisms (9 papers), Colorectal Cancer Treatments and Studies (8 papers) and Sleep and Wakefulness Research (8 papers). The work is most often cited by research in Molecular Medicine (1.2k citations), Hematology (1.3k citations), Genetics (825 citations), Pharmaceutical Science (269 citations) and Cancer Research (657 citations). Liang‐In Lin has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Ann‐Lii Cheng, Jen‐Kun Lin, Ying‐Jan Wang, Min‐Hsiung Pan, Chang‐Yao Hsieh, Yuan‐Soon Ho, Hwei‐Fang Tien, Da‐Liang Ou, Jih‐Luh Tang and Wen‐Chien Chou. Their work appears in journals such as Blood, Blood Cancer Journal, DNA repair, British Journal of Cancer and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact